Primary Health Properties (LSE: PHP)

Currency in GBP

Last close As at 26/01/2023

GBP1.13

0.60 (0.54%)

Market capitalisation

GBP1,497m

Primary Health Properties is a long-term investor in primary healthcare property in the UK and the Republic of Ireland. Assets are mainly long-let to GPs and the NHS or the HSE, organisations backed by the UK and Irish governments respectively.

Income visibility is strong, with long leases and upwards-only rents, 89% backed directly or indirectly by government bodies, little exposed to the economic cycle, or occupancy fluctuation. Health and social care planning suggests strong underlying demand for modern healthcare properties in both the UK and the Republic of Ireland.

Sector

Real Estate

Equity Analyst

Martyn King

Martyn King

Director, Financials

Key Management

  • Harry Hyman

    CEO

  • Richard Howell

    CFO

  • Steven Owen

    Chairman

Balance Sheet

Forecast net cash (£m)

1221.8

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 2.3 0.4 (21.2)
Relative (1.5) (9.2) (23.1)
52 week high/low 151.7p/98.7p

Financials

Primary Health Properties’ (PHP’s) H122 adjusted EPS increased 9.7% y-o-y, adjusted NTA per share by 3.5% to 120.8p and the adjusted NTA total return was 6.3%. PHP is on track to achieve its 6.5p annual target, its 26th year of unbroken DPS growth. Higher earnings were driven by growth in rental income and refinancing measures that lowered average debt cost. Costs were affected by inflation and investment in the operating platform, but the EPRA cost ratio remains the lowest in the REIT sector. In part due to inflation, rents are rising at an accelerating pace while 95% of debt costs are fixed/hedged. LTV of 43.1% remained well within PHP’s 40–50% target, above the mainstream commercial sector reflecting the security and visibility of cash flows. Despite ample liquidity and a strong investment pipeline, given financial market uncertainties, PHP is being prudent and selective about which projects to pursue. We forecast continued earnings and dividend growth.

Y/E Dec Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2020A 131.2 118.0 112.4 5.7 19.8 12.0
2021A 136.7 126.2 141.6 6.1 18.5 10.7
2022E 141.3 130.0 164.3 6.3 17.9 13.1
2023E 146.9 134.8 119.5 6.5 17.3 11.1

Thematics

Consumer

IPO apocalypse

TMT

ESG, moving beyond the box tick

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free